Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L Lehmann
Favorable Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Acute Promyelocytic Leukemia in Childhood
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Immunotherapy
Oncology
Allergy
Immunology
Clofarabine, Cytarabine, and Mitoxantrone in Refractory/Relapsed Acute Myeloid Leukemia: High Response Rates and Effective Bridge to Allogeneic Hematopoietic Stem Cell Transplantation
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Pcn126 - Direct Cost Study of Allogeneic Hematopoietic Stem Cell Transplantation (Ahsct) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients From the French Hospital Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Allogeneic Hemopoietic Stem Cell Transplants for Patients With Relapsed Acute Leukemia: Long-Term Outcome
Bone Marrow Transplantation
Transplantation
Hematology
Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
